Hyperlipidemia
📧 Sign up to get email alerts when something new happens for Hyperlipidemia.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2012-07-09FDA Approved: WELCHOL — Supplemental Application (Cosette Pharmaceuticals, Inc.)
FDA approved a supplemental application for WELCHOL (colesevelam hydrochloride) from Cosette Pharmaceuticals. The approval updates labeling …
-
CLINICAL_TRIALS trial_result · 2012-06-22Clinical Trial Update: Exenatide (Byetta ®) Regulation of Intestinal and Hepatic Lipoprotein Particle Production in Humans [NA]
The clinical trial evaluated how exenatide (Byetta) influences intestinal and hepatic lipoprotein particle production in adults with hyperli…
-
FDA approval · 2012-06-12FDA Approved: FLUVASTATIN — Original Application (Teva Pharmaceuticals USA, Inc.)
The FDA approved Teva's generic fluvastatin as an original application, enabling marketing of a generic statin product.
-
CLINICAL_TRIALS trial_result · 2012-06-01Clinical Trial Update: Pharmacokinetic Drug Interaction Between Rosuvastatin and Valsartan [Phase 1]
A Phase 1 pharmacokinetic study evaluated potential drug interaction between rosuvastatin and valsartan; the trial in hypertension and hyper…
-
FDA approval · 2012-05-29FDA Approved: ATORVASTATIN CALCIUM — Original Application (Mylan Pharmaceuticals Inc.)
FDA approves the atorvastatin calcium generic product from Mylan (Original Application) for use in lowering cholesterol.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2012-05-29FDA Approved: ATORVASTATIN CALCIUM — Original Application (Quallent)
The FDA approved Quallent's Abbreviated New Drug Application for atorvastatin calcium, establishing a generic atorvastatin calcium product. …
-
CLINICAL_TRIALS trial_result · 2012-05-28Clinical Trial Update: A Pilot Study to Improve Patient-Doctor Communication [NA]
A completed pilot study from Walter Reed National Military Medical Center evaluating a program to improve patient-doctor communication acros…
-
CLINICAL_TRIALS trial_result · 2012-05-24Clinical Trial Update: Effect of Lapaquistat Acetate Combined With Fenofibrate on Blood Cholesterol Levels [Phase 2]
Phase 2 clinical trial update evaluating the effect of combining lapaquistat acetate with fenofibrate on blood cholesterol levels in patient…
-
CLINICAL_TRIALS trial_result · 2012-05-17Clinical Trial Update: Effect of Low Calorie Diet With Rice Bran Oil on Cardiovascular Risk Factors in Hyperlipidemic Patients [NA]
This ClinicalTrials.gov update describes a study evaluating whether a low-calorie diet with rice bran oil affects cardiovascular risk factor…
-
FDA approval · 2012-05-03FDA Approved: PRAVASTATIN SODIUM — Supplemental Application (Aurobindo Pharma Limited)
FDA approved a supplemental application for Pravastatin Sodium from Aurobindo Pharma Limited, confirming continued approval of this generic …
-
CLINICAL_TRIALS trial_result · 2012-04-30Clinical Trial Update: Prevail-Us: A Study Of Pitavastatin 4 mg Vs. Pravastatin 40 mg In Patients With Primary Hyperlipidemia Or Mixed Dyslipidemia [Phase 4]
Phase 4 trial comparing pitavastatin 4 mg to pravastatin 40 mg in adults with primary hyperlipidemia or mixed dyslipidemia has completed and…
-
FDA label_change · 2012-04-26FDA Approved: SIMVASTATIN — Supplemental Application (NorthStar Rx LLC)
FDA approved a supplemental application for simvastatin submitted by NorthStar Rx LLC.
-
FDA approval · 2012-04-20FDA Approved: ATORVASTATIN CALCIUM — Supplemental Application (Sun Pharmaceutical Industries Inc.)
The FDA approves a supplemental application for atorvastatin calcium from Sun Pharmaceutical Industries Inc., resulting in a generic atorvas…
-
FDA approval · 2012-04-11FDA Approved: FLUVASTATIN SODIUM — Original Application (Mylan Pharmaceuticals Inc.)
FDA approved a generic version of fluvastatin sodium through an Original Application (ANDA) by Mylan Pharmaceuticals Inc.
-
CLINICAL_TRIALS trial_result · 2012-03-28Clinical Trial Update: Efficacy and Safety of Simvast Controlled Release (CR) and Zocor in Chronic Kidney Disease(CKD) Stage 3, 4 and 5 Patients With Hyperlipidemia [Phase 4]
Phase 4 trial update evaluating the efficacy and safety of simvastatin controlled-release (CR) and Zocor in patients with chronic kidney dis…
-
CLINICAL_TRIALS trial_result · 2012-03-22Clinical Trial Update: Compliance With Treatment For Patients With Hyperlipidemia
A completed clinical trial update on treatment compliance in patients with hyperlipidemia.
-
CLINICAL_TRIALS trial_result · 2012-03-16Clinical Trial Update: A Study Of Nutraceutical Drinks For Cholesterol (Evaluating Effectiveness and Tolerability) [NA]
A completed clinical trial evaluated nutraceutical drinks for hyperlipidemia to assess effectiveness and tolerability.
-
CLINICAL_TRIALS trial_result · 2012-03-07Clinical Trial Update: Lipid Management in Clinical Practice (MK-0524A-115)
Completed results from Merck's MK-0524A-115 trial on lipid management in clinical practice; results were posted in 2012.
-
FDA approval · 2012-03-02FDA Approved: SIMVASTATIN — Supplemental Application (NorthStar Rx LLC)
FDA approved a supplemental application for simvastatin submitted by NorthStar Rx LLC, completing the changes described in the supplemental …
-
FDA approval · 2012-03-01FDA Approved: FENOFIBRATE — Supplemental Application (Lupin Pharmaceuticals, Inc.)
FDA approves Lupin Pharmaceuticals' supplemental application for fenofibrate.
-
FDA approval · 2012-03-01FDA Approved: FENOFIBRATE — Original Application (Dr. Reddy's Laboratories Limited)
FDA approved Dr. Reddy's Laboratories Limited's original application (ANDA090859) for a generic fenofibrate product, authorizing its marketi…
-
FDA approval · 2012-02-28FDA Approved: LESCOL XL — Supplemental Application (Sandoz Inc)
FDA approved a supplemental application for LESCOL XL (fluvastatin sodium) filed by Sandoz Inc.
-
CLINICAL_TRIALS trial_result · 2012-02-17Clinical Trial Update: A Study of Torcetrapib/Atorvastatin vs Atorvastatin Alone or Placebo in Patients With High Cholesterol [Phase 3]
Phase 3 trial comparing torcetrapib in combination with atorvastatin versus atorvastatin alone or placebo in patients with hyperlipidemia; t…
-
CLINICAL_TRIALS trial_result · 2012-02-17Clinical Trial Update: Carotid B-mode Ultrasound Study to Compare Anti-Atherosclerotic Effect of Torcetrapib/Atorvastatin to Atorvastatin. [Phase 3]
A Phase 3 trial evaluating the anti-atherosclerotic effect of torcetrapib/atorvastatin versus atorvastatin in mixed hyperlipidemia was termi…
-
CLINICAL_TRIALS trial_result · 2012-02-17Clinical Trial Update: A Clinical Trial Comparing Torcetrapib/Atorvastatin To Simvastatin In Subjects With High Cholesterol (A5091031). [Phase 3]
A Phase 3 trial comparing torcetrapib/atorvastatin to simvastatin in subjects with high cholesterol was terminated.